Compliance First, Recording Innovation & Development

In September, the company received the 2026 Guangdong Provincial GMP Pharmaceutical Packaging Materials Annex Implementation Inspection conducted by the Guangdong Provincial Medical Products Administration; in October, it again received the annual supervision and inspection by the drug regulatory department of the Shunde District Market Supervision Administration. Inspectors conducted detailed verification of our production control, laboratory testing, material warehousing, change and deviation management, and record traceability for aluminum pharmaceutical ointment tubes and aluminum tubes for eye ointment, and recognized the compliant operation of our packaging quality system. They again strictly required us to continuously implement the GMP pharmaceutical packaging materials annex and relevant regulatory requirements, continuously consolidate full-process quality control capability, and establish a sounder quality management system.

Regarding the opinions raised during the inspections, the responsible departments immediately conducted root cause analysis and implemented rectifications item by item in closed loop.